1. Global Asthma Network (GAN). The Global Asthma Report. http://www.globalasthmareport.org (2018).
2. Conference Board of Canada. Cost Risk Analysis for Chronic Lung Disease in Canada. https://www.conferenceboard.ca/temp/3d4bc04b-9f21-4b67-98e3-1fd49ff48297/12-114_CostRiskAnalysisv4.pdf (2012).
3. Sadatsafavi, M. et al. Direct health care costs associated with asthma in British Columbia. Can. Respir. J. 17, 74–80 (2010).
4. Fischer, F., Lange, K., Klose, K., Greiner, W. & Kraemer, A. Barriers and strategies in guideline implementation—a scoping review. Healthcare (Basel) 4, 36 (2016).
5. Kotwani, A. Availability, price and affordability of asthma medicines in five Indian states. Int. J. Tuberc. Lung Dis. 13, 574–579 (2009).